Aurinia Pharmaceuticals

AUPHNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.060 B

$15.85 -1.74%

Close of 7 Aug 2026

Revenue

$283.1M

#2158 by revenue

Earnings

$287.2M

#859 by earnings

Shares outstanding

133,051,168

Latest filing cover page

P/E ratio

7.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#110Stoke TherapeuticsSTOK$2.11B
#111GH ResearchGHRS$2.08B
#112Aurinia PharmaceuticalsAUPH$2.06B
#113Zenas BioPharmaZBIO$2.05B
#114AbCellera BiologicsABCL$2.04B

Where these numbers come from

Share counts and financials for Aurinia Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.